Home » Topics » BioWorld Science

BioWorld Science
RSS

Organ-specific tumor microenvironment affects response to immunotherapy

Dec. 5, 2019

ALS exomes identify new culprit

Dec. 5, 2019

Tiziana begins phase I trial of oral foralumab in healthy volunteers

Dec. 4, 2019

Calmodulinopathy model used to study development of arrythmias

Dec. 4, 2019

Healthy volunteer safety data reported from phase IIb study of EB-01 in allergic contact dermatitis

Dec. 4, 2019

Xenikos initiates phase III study of T-Guard for steroid-refractory GvHD

Dec. 4, 2019

Phase II trial of CNSA-001 in PKU meets primary and secondary endpoints

Dec. 4, 2019

Abide Therapeutics identifies new monoglyceride lipase inhibitors

Dec. 4, 2019

Nuvation Bio discovers PARP inhibitors

Dec. 4, 2019

New macrophage metalloelastase inhibitors discovered at Foresee Pharmaceuticals

Dec. 4, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...